Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Infinity Pharmaceuti (INFI)

2.95 +0.05 (+1.72%)

10/16/2017  4:00pm

Open:

3.04

Pre. Close:

2.90

High:

3.14

Low:

2.66

Volume:

4,759,441

Market Cap:

149.53M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.18 - 3.21

3.21 - 3.24

Low:

2.55 - 2.59

2.59 - 2.62

Close:

2.88 - 2.95

2.95 - 3.01

Technical analysis  (as of: 2017-10-16 4:44:56 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 4.38     One year: 5.12

Support:

Support1: 2.11    Support2: 1.10

Resistance:

Resistance1: 3.75    Resistance2: 4.38

Pivot:

1.72

Moving Averages:

MA(5): 2.54     MA(20): 1.58

MA(100): 1.45     MA(250): 1.75

MACD:

MACD(12,26): 0.40     Signal(12,26,9): 0.20

%K %D:

%K(14,3): 78.84     %D(3): 84.59

RSI:

RSI(14): 69.94

52-Week:

High: 3.84  Low: 0.84  Change(%): 115.3

Average Vol(K):

3-Month: 202434  10-Days 765729

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
INFI has closed below upper band by 10.1%. Bollinger Bands are 599.9% wider than normal. The large width of the bands suggest high volatility as compared to INFI's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Thu, 05 Jan 2017 13:30:00 GMT
Infinity To Present At The 2017 BIO Investor Forum

Thu, 12 Oct 2017 14:03:45 GMT
Infinity Pharmaceuticals: Oral Presentation Implies Near-Term Upside

Mon, 16 Oct 2017 18:56:15 GMT
Just the Facts on Infinity Pharmaceuticals, Inc. (INFI)

Thu, 12 Oct 2017 18:33:45 GMT
Mid-Afternoon Market Update: Crude Oil Down 2%; Infinity Pharmaceuticals ...

Fri, 29 Sep 2017 21:30:06 GMT
Infinity Pharmaceuticals Inc. (INFI) Soars 16.67% on September 29

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

38.33

% Held by Insiders

2.57

% Held by Institutions

72.41

Shares Short (K)

1390

Shares Short Prior Month (K)

1430

Stock Financials

EPS

-1.390

EPS Est. Current Year

-0.920

EPS Est. Next Year

-1.500

EPS Est. Next Quarter

-0.200

Forward EPS

-1.494

Book Value (p.s.)

1.170

PEG Ratio

-0.05

Profit Margin

Operating Margin

Return on Assets (ttm)

-26.6

Return on Equity (ttm)

-78.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.369

Sales Per Share

EBITDA (p.s.)

-1.099

Qtrly Earnings Growth

Operating Cash Flow (M)

-82.94

Levered Free Cash Flow (M)

-49.17

FoxReading.com

Valuation

P/E

-2.12

P/E Growth Ratio

0.02

P/BV

2.52

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.